The top protein classifiers for AD versus control clinical diagnosis included members of the glia/inflammation panel, SMOC1 and MAPT (AUC = 0.84), followed by the synaptic 14-3-3 protein YWHAB (AUC = 0.82). This evidence concerns the gene YWHAB and Alzheimer disease.